Mantalaba, Cecilia M.
HRN: 26-43-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2025
CEFTRIAXONE 1G (VIAL)
03/01/2025
03/08/2025
IV
2g
OD
Presumptive PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes